Gesamter Bestand

Auflistung Nach Schlagwort "leukotriene receptor blocking agent"

Anzeige der Dokumente 1-7 von 7

    • Do we overtreat mild persistent asthma? 

      Loukides, S.; Kostikas, K.; Bakakos, P. (2009)

    • Enigma variations: The multi-faceted problems of pre-school wheeze 

      Chatziparasidis G., Bush A. (2022)
      Numerous publications on wheezing disorders in children younger than 6 years have appeared in the medical literature over the last decades with the aim of shedding light on the mechanistic pathways (endotypes) and treatment. ...

    • Impaired Cardiovascular Response to Exercise in Patients with Severe Asthma: A Case-Control Study 

      Georgopoulou A., Fotiadou L., Tryfon S., Daniil Z., Boutou A.K. (2022)
      Background: Although asthmatics may present reduced exercise capacity, data on their cardiovascular responses during exercise testing have been scarcely investigated. The aim of this pilot case-control study is to test: ...

    • Leukotriene antagonists: As firstline asthmatic therapy: A review 

      Wozniak, G.; Kotrotsiou, E.; Roupa, Z. (2005)
      Asthma is a chronic inflammatory disorder characterized by airflow obstruction. The development of leukotriene receptor antagonists and synthesis inhibitors in briefly described; and acute exercise, allergen, and aspirin ...

    • Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents a systematic review and meta-analysis 

      Miligkos M., Bannuru R.R., Alkofide H., Kher S.R., Schmid C.H., Balk E.M. (2015)
      Background: Leukotriene-receptor antagonists (LTRAs) are recommended as an alternative treatment in patients with mild asthma, but their effect compared with placebo is unclear. Purpose: To determine the benefits and harms ...

    • SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics 

      Papaioannou A.I., Fouka E., Tzanakis N., Antoniou K., Samitas K., Zervas E., Kostikas K., Bartziokas K., Porpodis K., Papakosta D., Tzouvelekis A., Gerogianni I., Kotsiou O., Makris M., Rovina N., Vlachou G., Markatos M., Vittorakis S., Katsoulis K., Papanikolaou I., Afthinos A., Katsaounou P., Steiropoulos P., Latsios D., Dimakou K., Koukidou S., Hillas G., Tryfon S., Kallieri M., Georgopoulou A., Avarlis P., Bakakos P., Markopoulou K., Gaki E., Paspala A., Kyriakaki Z., Gourgoulianis K.I., Papiris S., Loukides S. (2022)
      Background: At the beginning of the pandemic, there have been considerable concerns regarding coronavirus disease 2019 (COVID-19) severity and outcomes in patients with severe asthma treated with biologics. Objective: To ...

    • Takotsubo cardiomyopathy: A known unknown foe of asthma 

      Kotsiou O.S., Douras A., Makris D., Mpaka N., Gourgoulianis K.I. (2017)
      Introduction: Patients with uncontrolled asthma are at a greater risk of asthma attacks requiring emergency room visits or hospital admissions. Takotsubo cardiomyopathy is potentially a significant complication in a course ...